Louisiana 2018 2018 Regular Session

Louisiana Senate Bill SB28 Comm Sub / Analysis

                    The original instrument and the following digest, which constitutes no part of the
legislative instrument, were prepared by Christine Arbo Peck.
DIGEST
SB 28 Original	2018 Regular Session	Mills
Present law provides that pharmaceutical manufacturers who engage in marketing directly to a
prescriber may inform the prescribers of an internet website containing prescription drug price
information.
Proposed law exempts veterinarians and certain pharmaceutical marketers of prescription drugs
manufactured exclusively for nonhuman consumption from the provisions established in present law
regarding disclosure of prescription drug price information.
Present law requires prescribers to access the prescription drug monitoring program prior to initially
prescribing an opioid and every 90 days if the course of treatment continues.
Proposed law exempts veterinarians from accessing the prescription monitoring program prior to
prescribing an opioid and every 90 days if the course of treatment continues.
Present law requires prescribers of controlled dangerous substances to obtain three credit hours of
continuing education on drug diversion training, best practice prescribing of controlled substances,
appropriate treatment for addiction, and other matters deemed relevant by their respective licensing
board.
Proposed law exempts veterinarians from continuing education requirements for prescribers of
controlled dangerous substances.
Effective August 1, 2018.
(Adds R.S. 37:1251(D) and R.S. 40:978(F)(3) and 978.3(E))